Listed

Amneal Pharmaceuticals, Inc.

AMRXNasdaqCIK 1723128HealthcareFiscal year ends Dec 31

Reports and events: 191 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Amneal Pharmaceuticals, Inc., Reports and events
FiledFormWhat it isAccession number
2022-05-0406:11 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001723128-22-000012
2022-03-2508:00 ETDEF 14AProxy statementPeriod 2022-05-090001308179-22-000119
2022-03-1617:20 ET8-K5.02 Departure or appointment of officers or directors0001193125-22-077358
2022-03-0206:12 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001723128-22-000008
2022-03-0116:45 ET10-KAnnual reportPeriod 2021-12-310001723128-22-000006
2022-01-1917:32 ETSC 13D/AOwnership report, active investor, amended0001387131-22-000440
2022-01-1108:00 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure0001193125-22-006322
2022-01-0506:16 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-002140
2021-11-0816:43 ET10-QQuarterly reportPeriod 2021-09-300001723128-21-000039
2021-11-0306:17 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001723128-21-000035
2021-08-0916:05 ET10-QQuarterly reportPeriod 2021-06-300001723128-21-000032
2021-08-0906:15 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001723128-21-000028
2021-05-1016:24 ET8-K5.07 Shareholder vote results0001193125-21-156284
2021-05-0716:16 ET10-QQuarterly reportPeriod 2021-03-310001723128-21-000023
2021-05-0706:17 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001723128-21-000020
2021-04-0508:03 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-105627
2021-03-2408:00 ETDEF 14AProxy statementPeriod 2021-05-050001308179-21-000093
2021-03-0116:10 ET10-KAnnual reportPeriod 2020-12-310001723128-21-000013
2021-02-2606:35 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001723128-21-000008
2021-02-1616:14 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-21-044889
2021-01-1206:15 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-006720
2020-12-1816:05 ET8-K5.02 Departure or appointment of officers or directors0001193125-20-321461
2020-11-0616:19 ET10-QQuarterly reportPeriod 2020-09-300001723128-20-000026
2020-11-0606:13 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001723128-20-000023
2020-08-0616:22 ET10-QQuarterly reportPeriod 2020-06-300001723128-20-000013
2020-08-0606:09 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001723128-20-000010
2020-08-0416:16 ET8-K5.02 Departure or appointment of officers or directors0001193125-20-209316
2020-05-1116:32 ET10-QQuarterly reportPeriod 2020-03-310001564590-20-024256
2020-05-1106:47 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-20-023833
2020-05-0807:43 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001193125-20-136972
2020-04-1716:05 ET8-K/A9.01 Financial statements and exhibits0001193125-20-110622
2020-03-2316:31 ETDEF 14AProxy statementPeriod 2020-05-050001308179-20-000070
2020-03-1217:19 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-071730
2020-03-0216:33 ET10-KAnnual reportPeriod 2019-12-310001564590-20-008179
2020-02-2616:55 ET8-K5.02 Departure or appointment of officers or directors0001193125-20-050188
2020-02-2606:50 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-20-006564
2020-02-2016:49 ET8-K/A5.02 Departure or appointment of officers or directors0001193125-20-043613
2020-02-2016:47 ET8-K/A5.02 Departure or appointment of officers or directors0001193125-20-043609
2020-02-0419:51 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-20-023178
2020-01-1510:32 ET8-K7.01 Regulation FD disclosure0001193125-20-007787
2019-12-1616:50 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-19-315267
2019-12-1016:51 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-19-310283
2019-11-0720:09 ET10-QQuarterly reportPeriod 2019-09-300001564590-19-041240
2019-11-0606:54 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-19-040651
2019-10-1112:07 ET8-K5.07 Shareholder vote results0001193125-19-266540
2019-09-1117:14 ETSC 13D/AOwnership report, active investor, amended0000898432-19-001162
2019-08-2617:27 ETSC 13D/AOwnership report, active investor, amended0000898432-19-001109
2019-08-2617:27 ETSC 13D/AOwnership report, active investor, amended0000898432-19-001108
2019-08-0720:39 ETSC 13D/AOwnership report, active investor, amended0000914121-19-002138
2019-08-0720:37 ETSC 13D/AOwnership report, active investor, amended0000914121-19-002136

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 02:45 ET. Listed shows no prices and gives no investment advice.